1. PET Imaging of GPR44 by Antagonist [11C]MK-7246 in Pigs
- Author
-
Pierre Cheung, Bo Zhang, Emmi Puuvuori, Sergio Estrada, Mohammad A. Amin, Sofie Ye, Olle Korsgren, Luke R. Odell, Jonas Eriksson, and Olof Eriksson
- Subjects
pancreas imaging ,diabetes ,biomarker ,PET ,PTGDR2 ,Biology (General) ,QH301-705.5 - Abstract
A validated imaging marker for beta-cell mass would improve understanding of diabetes etiology and enable new strategies in therapy development. We previously identified the membrane-spanning protein GPR44 as highly expressed and specific to the beta cells of the pancreas. The selective GPR44 antagonist MK-7246 was radiolabeled with carbon-11 and the resulting positron-emission tomography (PET) tracer [11C]MK-7246 was evaluated in a pig model and in vitro cell lines. The [11C]MK-7246 compound demonstrated mainly hepatobiliary excretion with a clearly defined pancreas, no spillover from adjacent tissues, and pancreatic binding similar in magnitude to the previously evaluated GPR44 radioligand [11C]AZ12204657. The binding could be blocked by preadministration of nonradioactive MK-7246, indicating a receptor-binding mechanism. [11C]MK-7246 showed strong potential as a PET ligand candidate for visualization of beta-cell mass (BCM) and clinical translation of this methodology is ongoing.
- Published
- 2021
- Full Text
- View/download PDF